Fisher And Paykel Healthcare Corpo revenue and financials

FPH · ASX · AUD

$37.69+0.96%+$0.36

Close · October 7, 2026

In the fiscal year ended March 2026, Fisher And Paykel Healthcare Corpo reported revenue of $2.31B (+80.30% year over year). Net income was $468.5M, a net margin of 20.3%.

Annual revenue · 2026: $2.31B

$1.59B2023
$1.76B2024
$1.28B2025
$2.31B2026

Fiscal year ending in March. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: +80.30%; FY to Mar 2026 vs FY to Mar 2025
Net income growth: +24.20%; FY to Mar 2026 vs FY to Mar 2025
Net margin: 20.3%; FY to Mar 2025: 29.5%

Financial data

Amounts in millions of NZD; per-share values in NZD; shares in millions.

Balance sheet · Quarterly
Item	Q1 2026	Q1 2025
Total assets	2,854	2,551
Current assets	1,152	935
Cash and equivalents	461	265
Receivables	329	305
Inventory	327	343
Net property, plant and equipment	1,407	1,339
Other intangible assets	72.7	82.1
Current liabilities	498	500
Accounts payable	56.7	52.9
Long-term debt	52.5	—
Total debt	146	153
Total liabilities	738	660
Total equity (incl. minority)	2,115	1,890
Retained earnings	1,443	1,227